Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Human papillomavirus type 16 evaluated as a predictor of cervical precancer
September 15th, 2005
Human papillomavirus type 16 was recently evaluated as a predictor of cervical precancer. According to scientists in the United States, "The 2-year absolute risk for cervical precancer attributable to infection by human papillomavirus type 16 (HPV16), the most common and oncogenic HPV type, in the millions of women diagnosed annually with equivocal or mildly abnormal cytology has not been definitively evaluated." P.E. Castle and colleagues tested "baseline cervical specimens of 5060 women with equivocal (atypical squamous cells of undetermined significance [ASCUS]) or mildly abnormal (low-grade squamous intraepithelial lesion [LSIL]) cytology for HPV DNA using Hybrid...
Source: Women's Health Weekly (2005-09-15)
|
